Evidence map›Paper›PMID 31781617›Full record

ArticleBioMed research international2019

VLPs Derived from the CCMV Plant Virus Can Directly Transfect and Deliver Heterologous Genes for Translation into Mammalian Cells.

María V Villagrana-Escareño, Elizabeth Reynaga-Hernández, Othir G Galicia-Cruz, Ana L Durán-Meza, Viridiana De la Cruz-González, Carmen Y Hernández-Carballo, Jaime Ruíz-García

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals.Bioengineering (Basel, Switzerland) · 2024
    Review
  10. Molecular pharmaceutics · 2024
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Virus-like Particles: Fundamentals and Biomedical Applications.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

María V Villagrana-EscareñoPhysical Biology Laboratory, Institute of Physics, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Elizabeth Reynaga-HernándezPhysical Biology Laboratory, Institute of Physics, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Othir G Galicia-CruzAnalytical Pharmacology Laboratory, Faculty of Medicine, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Ana L Durán-MezaPhysical Biology Laboratory, Institute of Physics, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Viridiana De la Cruz-GonzálezPhysical Biology Laboratory, Institute of Physics, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Carmen Y Hernández-CarballoBiophysics Laboratory, Institute of Physics, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.
Jaime Ruíz-GarcíaPhysical Biology Laboratory, Institute of Physics, Autonomous University of San Luis Potosí, San Luis Potosí, Mexico.ORCID https://orcid.org/0000-0003-3730-3825
Autonomous University of San Luis Potosí · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Virus-like particles (VLPs) are being used for therapeutic developments such as vaccines and drug nanocarriers. Among these, plant virus capsids are gaining interest for the formation of VLPs because they can be safely handled and are noncytotoxic. A paradigm in virology, however, is that plant viruses cannot transfect and deliver directly their genetic material or other cargos into mammalian cells. In this work, we prepared VLPs with the CCMV capsid and the mRNA-EGFP as a cargo and reporter gene. We show, for the first time, that these plant virus-based VLPs are capable of directly transfecting different eukaryotic cell lines, without the aid of any transfecting adjuvant, and delivering their nucleic acid for translation as observed by the presence of fluorescent protein. Our results show that the CCMV capsid is a good noncytotoxic container for genome delivery into mammalian cells.

Indexed as

Gene Transfer TechniquesAnimalsBromovirusCapsid ProteinsCell LineEukaryotic CellsGenes, ReporterGreen Fluorescent ProteinsHeLa CellsHumansPlant VirusesTransfectionVaccines, Virus-Like ParticleVirus AssemblyCapsid ProteinsGreen Fluorescent ProteinsVaccines, Virus-Like Particle

Identifiers

PMID31781617
PMCPMC6855080
OpenAlexW2982677925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.